Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d007df0e92f4a5cb4c6420e2c4309c1 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D455-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-475 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D455-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475 |
filingDate |
2014-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef7d3dfa2ad4f56e39f1e670e735781d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8beffcaa8a1e29ef23f8d115ae7f869b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5be7106e789064c8a0c64163274a6bd2 |
publicationDate |
2014-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2014323511-A1 |
titleOfInvention |
Chemotherapeutic for inducing an msh2 dependent apoptotic pathway |
abstract |
Active compounds include compounds of Formula I and Formula II are described: n n n n n n n n n n along with compositions containing the same and methods of use thereof. |
priorityDate |
2013-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |